Steady Expansion Forecast for Prenatal DNA Sequencing Market, Projected to Reach $5.29 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Prenatal DNA Sequencing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The prenatal DNA sequencing industry has experienced a swift expansion in its market size over the past few years. The market is anticipated to grow from $2.5 billion in 2024 to $2.84 billion in 2025, yielding a compound annual growth rate (CAGR) of 13.9%. Factors such as evolving patient choices, advancements in medical technology and research, adoption of non-invasive tests, increased maternal age, and enhancement in accuracy and dependability have contributed to the growth during the historical period.

Prenatal DNA Sequencing Market Size Forecast: What's the Projected Valuation by 2029?
The market size for prenatal DNA sequencing is predicted to experience swift expansion in the upcoming years, with an estimated value of $5.3 billion by 2029, and a compound annual growth rate (CAGR) of 16.8%. This predicted escalation for the forecast period can be traced back to factors such as client aspirations for early diagnosis, the increasing age of mothers and associated pregnancy hazards, public health policies, regulatory assistance and guidelines, and progress in data comprehension. Significant trends for the projected period encompass research and development activities, ethical and regulatory matters, advanced tools for data interpretation, the incorporation of precision medicine, and genetic counseling during pregnancy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

What Are the Drivers Transforming the Prenatal DNA Sequencing Market?
The rise in cancer prevalence is predicted to fuel the expansion of the prenatal DNA sequencing market. Cancer is a condition where certain body cells proliferate uncontrollably and invade other areas. In cancer cases, prenatal DNA sequencing is employed to uncover fetal aneuploidy in maternal plasma and to diagnose the infant's cancer. This sequencing process unveils inherited or germline DNA alternations that increase a person's susceptibility to cancer development. For instance, as per the American Cancer Society, a nonprofit cancer advocacy entity based in the US, there was an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, indicating a growth rate of 3.16%. Consequently, the increasing incidence of cancer is propelling the growth of the prenatal DNA sequencing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9015&type=smp

What Long-Term Trends Will Define the Future of the Prenatal DNA Sequencing Market?
The introduction of innovative products is a significant trend getting traction in the prenatal DNA sequencing industry. Big firms in this sector are concentrating on the creation of innovative offerings to reinforce their market standing. For instance, Juno Diagnostics, Inc., an American health tech firm that makes valuable genetic information more accessible, rolled out a noninvasive prenatal screening test called 'Hazel' in November 2022. This test is exceptional as it poses no miscarriage risk and can be conducted as early as 9 weeks into the pregnancy with just a small blood sample. It examines the pregnancy for prevalent genetic anomalies resulting from surplus or absent chromosomes like Down syndrome, Edwards syndrome, and Patau syndrome.

Which Segments in the Prenatal DNA Sequencing Market Offer the Most Profit Potential?
The prenatal DNA sequencing market covered in this report is segmented -

1) By Type: Genetic Diseases, Nonhereditary Diseases
2) By Application: Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS (Acquired Immunodeficiency Syndrome), Cancer, Other Applications
3) By End User: Academic Research, Clinical Research, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Genetic Diseases: Monogenic Disorders, Chromosomal Abnormalities
2) By Nonhereditary Diseases: Infectious Diseases, Maternal Health Conditions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9015&type=smp

Which Firms Dominate the Prenatal DNA Sequencing Market by Market Share and Revenue in 2025?
Major companies operating in the prenatal DNA sequencing market include Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, GeneDx Inc., Genoma SA, Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc.

Which Regions Offer the Highest Growth Potential in the Prenatal DNA Sequencing Market?
North America was the largest region in the prenatal DNA sequencing market in 2024. The regions covered in the prenatal DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9015

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.